Microsoft and Boehringer Ingelheim Announce Strategic AI Collaboration

Microsoft and Boehringer Ingelheim have formed a strategic collaboration to utilize artificial intelligence in clinical development processes. The partnership will explore the use of Digital Patient Twins to predict disease progression and treatment outcomes. This initiative aims to improve the efficiency of bringing safe and effective therapies to patients by integrating AI insights into the clinical development value chain.